Transchem Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Transchem Ltd is ₹ 418.75 as of 23 Oct 15:30 . The P/E Ratio of Transchem Ltd changed from 0.9 on March 2021 to 46.3 on March 2026 . This represents a CAGR of 92.85% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Transchem Ltd changed from ₹ 20.44 crore on March 2021 to ₹ 199.08 crore on March 2026 . This represents a CAGR of 46.14% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Transchem Ltd for the Jun '26 is ₹ 5.11 crore as compare to the Mar '26 revenue of ₹ 3.7 crore. This represent the growth of 38.11% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Transchem Ltd for the Jun '26 is ₹ 4.41 crore as compare to the Mar '26 ebitda of ₹ 2.39 crore. This represent the growth of 84.52% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Transchem Ltd changed from ₹ 1.66 crore to ₹ 3.42 crore over 9 quarters. This represents a CAGR of 37.89% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Transchem Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Transchem Ltd

Transchem Limited (TL) was incorporated as a private limited company on 18 November, 1976 and converted into a public limited company on 13 April, 1992.
Initially, Company was in the business of Mushroom production and operated a 100% Export Oriented Unit from its manufacturing plant situated at Village Bebadohol, Pune.
Due to change in international horticulture scenario, the mushroom plant of the Company was non-operational since several years. TL came out with a public issue of 14.22 lac zero-interest FCDs of Rs.120 at par aggregating Rs.17.07 crores in Oct.'93, to meet part of the capital cost, and to finance the margin money for working capital, etc, at a project cost of Rs.27 crores.
The company manufactures bulk drugs in Maharashtra.
The company's main products are frusemide, fenbendazole and albendazoie.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Transchem Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Transchem Ltd is 512 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Transchem Ltd stock price is INR ₹418.75. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Transchem Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.